Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shouval

Showing results (511-520 of 726) with videos related to

Pageof 73
Sort By:
Frontiers in Immunology|March 3, 2020
Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBDLael Werner, Yu Nee Lee, Erez Rechavi, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
European Journal of Pediatrics|February 20, 2024
A significant increase in anthropometric indices during long-term follow-up of pediatric patients with celiac disease, with no endocrine disordersAlexander Krauthammer, Anat Guz-Mark, Noam Zevit, et al.
The New England Journal of Medicine|March 10, 2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BChing-Lung Lai, Daniel Shouval, Anna S Lok, et al.
Transplantation and Cellular Therapy|February 26, 2022
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphomaMeirav Kedmi, Roni Shouval, Shalev Fried, et al.
Clinical and Experimental Immunology|December 18, 2018
Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitisL Werner, M Y Nunberg, E Rechavi, et al.
Cell|August 2, 2014
The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancyRuth Scherz-Shouval, Sandro Santagata, Marc L Mendillo, et al.
Bone Marrow Transplantation|September 21, 2022
Management of prolonged cytopenia following CAR T-cell therapyMagdalena Corona, Roni Shouval, Ana Alarcón, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral propertiesEithan Galun, Rachel Eren, Rifaat Safadi, et al.
Leukemia & Lymphoma|August 11, 2023
Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphomaShalev Fried, Eden Shkury, Orit Itzhaki, et al.
Pageof 73

Showing results (511-520 of 726) with videos related to

Sort By:
Pageof 73
Frontiers in Immunology|March 3, 2020
Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBDLael Werner, Yu Nee Lee, Erez Rechavi, et al.
Bone Marrow Transplantation|December 3, 2020
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphomaIvetta Danylesko, Roni Shouval, Noga Shem-Tov, et al.
European Journal of Pediatrics|February 20, 2024
A significant increase in anthropometric indices during long-term follow-up of pediatric patients with celiac disease, with no endocrine disordersAlexander Krauthammer, Anat Guz-Mark, Noam Zevit, et al.
The New England Journal of Medicine|March 10, 2006
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BChing-Lung Lai, Daniel Shouval, Anna S Lok, et al.
Transplantation and Cellular Therapy|February 26, 2022
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphomaMeirav Kedmi, Roni Shouval, Shalev Fried, et al.
Clinical and Experimental Immunology|December 18, 2018
Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitisL Werner, M Y Nunberg, E Rechavi, et al.
Cell|August 2, 2014
The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancyRuth Scherz-Shouval, Sandro Santagata, Marc L Mendillo, et al.
Bone Marrow Transplantation|September 21, 2022
Management of prolonged cytopenia following CAR T-cell therapyMagdalena Corona, Roni Shouval, Ana Alarcón, et al.
Hepatology (Baltimore, Md.)|March 1, 2002
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral propertiesEithan Galun, Rachel Eren, Rifaat Safadi, et al.
Leukemia & Lymphoma|August 11, 2023
Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphomaShalev Fried, Eden Shkury, Orit Itzhaki, et al.
Pageof 73